Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.350 +0.020 (+1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Organogenesis Holdings (NASDAQ:ORGO 
Via Benzinga
News headline image
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
News headline image
Thinking About Buying Stock In AMC Entertainment, Romeo Power Or Inovio Pharmaceuticals? ↗
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b... 
Via Benzinga
News headline image
Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals ↗
Following the recent pullback in Inovio Pharmaceuticals Inc.’s (NASDAQ: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022 ↗
Upgrades According to Seaport Global, the prior rating for KB Home (NYSE: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Barclays cut Netflix, Inc. (NASDAQ: NFLX) price target from $675 to $425. Netflix shares fell 19.6% to $408.58 in pre-market trading. Keybanc cut Chipotle Mexican Grill, Inc... 
Via Benzinga
Growing Acceptance Of Digital Health Services is a Huge Boon for Healthcare Cloud Computing Market
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional... 
Via FinancialNewsMedia
News headline image
Bill Gates Says Misinformation Related To Fauci, Himself Doesn't 'Make Sense,' Talks COVID-19 After Omicron ↗
Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates answered questions related to COVID-19 on Twitter Tuesday. What Happened: The questions to Gates were routed through... 
Via Benzinga
News headline image
Stocks Hitting New 52-Week Lows Today ↗
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
Via Benzinga
News headline image
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street ↗
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current 
Via Talk Markets
News headline image
If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now ↗
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 29.2... 
Via Benzinga
News headline image
Market Briefing For Thursday, Dec. 23 ↗
'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday. 
Via Talk Markets
News headline image
Why Jim Cramer Likes MGM Growth Properties ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enterprise Products Partners L.P. (NYSE: 
Via Benzinga
News headline image
Why You Should Buy Moderna Stock at Every Dip ↗
Moderna’s cash growth will continue as demand for booster shots and vaccines for the omicron variant increase, giving a boost to MRNA stock. 
Via InvestorPlace
News headline image
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week ↗
These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant. 
Via The Motley Fool
News headline image
The 'Highly Mutated Virus' Signals A Need For Annual Shots: BioNTech CEO ↗
The omicron variant signals a need for annual Covid shots, BioNTech's CEO said. 
Via Investor's Business Daily
News headline image
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs ↗
One of these stocks is poised to rebound, but the other still looks very risky. 
Via The Motley Fool
Topics Economy
News headline image
Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat ↗
Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant. 
Via Investor's Business Daily
News headline image
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail? ↗
Smaller companies are working on next-generation approaches to Covid treatment. 
Via Investor's Business Daily
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
News headline image
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant ↗
Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa. It said that the shot would be... 
Via Benzinga
News headline image
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen ↗
Both vaccine makers still have big hurdles to jump. 
Via The Motley Fool
News headline image
Does This News Make Inovio Pharmaceuticals Stock a Buy? ↗
The company is closer than ever to launching its coronavirus vaccine -- but will it be good enough to make the stock worth purchasing? 
Via The Motley Fool
News headline image
Why Inovio Stock Is Rising Today ↗
The company received a green light to begin a U.S. phase 3 study of its COVID-19 vaccine candidate. 
Via The Motley Fool
News headline image
Inovio Pharmaceuticals (INO) Q3 2021 Earnings Call Transcript ↗
INO earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News ↗
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S.... 
Via Benzinga
News headline image
Why Shares of Inovio Pharmaceuticals Rallied Today ↗
The FDA lifted its hold on the next step of its COVID-19 vaccine trial, although that doesn't mean much at this point. 
Via The Motley Fool
News headline image
RBLX Stock Alert: What Is Going on With Roblox Shares Today? ↗
Roblox (RBLX) stock is soaring higher on Tuesday following the release of the company's earnings report for the third quarter of 2021. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.